Super Avana combines the rapid-acting PDE‑5 inhibitor avanafil with the on-demand SSRI dapoxetine, addressing both erectile dysfunction and premature ejaculation in a single tablet. Clinical evidence robustly supports avanafil’s efficacy in improving erectile function, penetration success, and intercourse duration, with a favorable safety and tolerability profile. Real-world data further affirm high patient satisfaction and functional outcomes.